Effect of noradrenergic system on the anxiolytic-like effect of DOI (5-HT2A/2C agonists) in the four-plate test

Psychopharmacology

Volumn 183, Issue 4, 2006, Pages 471-481

  Massé, Fabienne ^a   Hascoët, Martine ^a   Dailly, Eric ^a   Bourin, Michel ^a  

^a UNIVERSITÉ DE NANTES   (France)

Author keywords

2 Adrenoceptors; 5 HT2 receptors; DOI; Four plate test; Mice

Indexed keywords

2 BROMO N (2 CHLOROETHYL) N ETHYLBENZYLAMINE; 4 IODO 2,5 DIMETHOXYAMPHETAMINE; ADRAFINIL; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 1 ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA ADRENERGIC RECEPTOR; ANXIOLYTIC AGENT; CLONIDINE; FENCLONINE METHYL ESTER; GUANABENZ; IDAZOXAN; PRAZOSIN; SEROTONIN 2 RECEPTOR; SEROTONIN 2A AGONIST; SEROTONIN 2C AGONIST;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; EXPERIMENTAL TEST; FOUR PLATE TEST; LOCOMOTION; MALE; MOUSE; NONHUMAN; NORADRENERGIC SYSTEM; PRIORITY JOURNAL; TRANQUILIZING ACTIVITY;

ADRENERGIC ALPHA-AGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; AMPHETAMINES; ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY; BENZYLAMINES; BRAIN CHEMISTRY; DIAZEPAM; DOPAMINE; GABA MODULATORS; MALE; MICE; MOTOR ACTIVITY; NEUROTOXINS; NOREPINEPHRINE; SEROTONIN; SEROTONIN AGONISTS;

EID: 28344441011     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-005-0220-3     Document Type: Article

References (64)

1. Adell A, Artigas F (1999) Regulation of the release of 5-hydroxytryptamine in the median raphe nucleus of the rat by catecholaminergic afferents. Eur J Neurosci 11:2305-2311
2. Aron C, Simon P, Larousse C, Boissier JR (1971) Evaluation of a rapid technique for detecting minor tranquilizers. Neuropharmacology 10:459-469
3. Artaiz I, Zazpe A, Del Rio J (1998) Characterization of serotonergic mechanisms involved in the behavioural inhibition induced by 5-hydroxytryptophan in a modified light-dark test in mice. Behav Pharmacol 9:103-112
4. Baker GB, Coutts RT, Rao TS (1987) Neuropharmacological and neurochemical properties of N-(2-cyanoethyl)-2-phenylethylamine, a prodrug of 2-phenylethylamine. Br J Pharmacol 92:243-255
5. Bhana N, Goa KL, McClellan KJ (2000) Dexmedetomidine. Drugs 59:263-268; discussion 269-270
6. Boissier JR, Simon P (1965) Action of caffeine on the spontaneous motility of the mouse. Arch Int Pharmacodyn Ther 158:212-221
7. Bortolozzi A, Amargos-Bosch M, Adell A, Diaz-Mataix L, Serrats J, Pons S, Artigas F (2003) In vivo modulation of 5-hydroxytryptamine release in mouse prefrontal cortex by local 5-HT (2A) receptors: effect of antipsychotic drugs. Eur J Neurosci 18: 1235-1246
8. Bourin M, Hascoet M, Mansouri B, Colombel MC, Bradwejn J (1992) Comparison of behavioral effects after single and repeated administrations of four benzodiazepines in three mice behavioral models. J Psychiatry Neurosci 17:72-77
9. Bourin M, Massé F, Dailly E, Hascoët M (2005) Anxiolytic-like effect of milnacipran in the four-plate test in mice: mechanism of action. Pharmacol Biochem Behav 81:645-656
10. Brodie MS, Bunney EB (1996) Serotonin potentiates dopamine inhibition of ventral tegmental area neurons in vitro. J Neurophysiol 76:2077-2082
11. Brunello N, Blier P, Judd LL, Mendlewicz J, Nelson CJ, Souery D, Zohar J, Racagni G (2003) Noradrenaline in mood and anxiety disorders: basic and clinical studies. Int Clin Psychopharmacol 18:191-202
12. Cathala L, Guyon A, Eugene D, Paupardin-Tritsch D (2002) Alpha2-adrenoceptor activation increases a cationic conductance and spontaneous GABAergic synaptic activity in dopaminergic neurones of the rat substantia nigra. Neuroscience 115:1059-1065
13. Cecchi M, Khoshbouei H, Javors M, Morilak DA (2002a) Modulatory effects of norepinephrine in the lateral bed nucleus of the stria terminalis on behavioral and neuroendocrine responses to acute stress. Neuroscience 112:13-21
14. Cecchi M, Khoshbouei H, Morilak DA (2002b) Modulatory effects of norepinephrine, acting on alpha 1 receptors in the central nucleus of the amygdala, on behavioral and neuroendocrine responses to acute immobilization stress. Neuropharmacology 43:1139-1147
15. Chiang C, Aston-Jones G (1993) A 5-hydroxytryptamine2 agonist augments gamma-aminobutyric acid and excitatory amino acid inputs to noradrenergic locus coeruleus neurons. Neuroscience 54:409-420
16. Cryan JF, Page ME, Lucki I (2002) Noradrenergic lesions differentially alter the antidepressant-like effects of reboxetine in a modified forced swim test. Eur J Pharmacol 436:197-205
17. Dailly E, Chenu F, Petit-Demouliere B, Bourin M (2005) Specificity and efficacy of noradrenaline, serotonin depletion in discrete brain areas of Swiss mice by neurotoxins. J Neurosci Methods (in press). DOI 10.1016/j.jneumeth.2005. 06.008
18. de Angelis L (1995) Effects of valproate and lorazepam on experimental anxiety: tolerance, withdrawal, and role of clonidine. Pharmacol Biochem Behav 52:329-333
19. Dennis T, L'Heureux R, Carter C, Scatton B (1987) Presynaptic alpha-2 adrenoceptors play a major role in the effects of idazoxan on cortical noradrenaline release (as measured by in vivo dialysis) in the rat. J Pharmacol Exp Ther 241:642-649
20. Done CJ, Sharp T (1992) Evidence that 5-HT2 receptor activation decreases noradrenaline release in rat hippocampus in vivo. Br J Pharmacol 107:240-245
21. Dursun SM, Handley SL (1993) The effects of alpha 2-adrenoceptor antagonists on the inhibition of 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI)-induced head shakes by 5-HT1A receptor agonists in the mouse. Br J Pharmacol 109:1046-1052
22. French N (1995) Alpha 2-adrenoceptors and 12 sites in the mammalian central nervous system. Pharmacol Ther 68:175-208
23. Fritschy JM, Grzanna R (1989) Immunohistochemical analysis of the neurotoxic effects of DSP-4 identifies two populations of noradrenergic axon terminals. Neuroscience 30:181-197
24. Fritschy JM, Grzanna R (1991) Selective effects of DSP-4 on locus coeruleus axons: are there pharmacologically different types of noradrenergic axons in the central nervous system? Prog Brain Res 88:257-268
25. Gobert A, Millan MJ (1999) Serotonin (5-HT)2A receptor activation enhances dialysate levels of dopamine and noradrenaline, but not 5-HT, in the frontal cortex of freely-moving rats. Neuropharmacology 38:315-317
26. Gorea E, Adrien J (1988) Serotonergic regulation of noradrenergic coerulean neurons: electrophysiological evidence for the involvement of 5-HT2 receptors. Eur J Pharmacol 154:285-291
27. Graeff FG, Netto CF, Zangrossi H Jr (1998) The elevated T-maze as an experimental model of anxiety. Neurosci Biobehav Rev 23:237-246
28. Haddjeri N, Blier P, de Montigny C (1996) Effect of the alpha-2 adrenoceptor antagonist mirtazapine on the 5-hydroxytryptamine system in the rat brain. J Pharmacol Exp Ther 277:861-871
29. Haddjeri N, de Montigny C, Blier P (1997) Modulation of the firing activity of noradrenergic neurones in the rat locus coeruleus by the 5-hydroxtryptamine system. Br J Pharmacol 120:865-875
30. Hamada S, Senzaki K, Hamaguchi-Hamada K, Tabuchi K, Yamamoto H, Yamamoto T, Yoshikawa S, Okano H, Okado N (1998) Localization of 5-HT2A receptor in rat cerebral cortex and olfactory system revealed by immunohistochemistry using two antibodies raised in rabbit and chicken. Brain Res Mol Brain Res 54:199-211
31. Handley SL, Mithani S (1984) Effects of alpha-adrenoceptor agonists and antagonists in a maze-exploration model of 'fear'-motivated behaviour. Naunyn Schmiedebergs Arch Pharmacol 327:1-5
32. Hascoet M, Bourin M, Colombel MC, Fiocco AJ, Baker GB (2000) Anxiolytic-like effects of antidepressants after acute administration in a four-plate test in mice. Pharmacol Biochem Behav 65:339-344
33. Johnston AL, File SE (1989) Yohimbine's anxiogenic action: evidence for noradrenergic and dopaminergic sites. Pharmacol Biochem Behav 32:151-156
34. Khoshbouei H, Cecchi M, Dove S, Javors M, Morilak DA (2002) Behavioral reactivity to stress: amplification of stress-induced noradrenergic activation elicits a galanin-mediated anxiolytic effect in central amygdala. Pharmacol Biochem Behav 71:407-417
35. La Marca S, Dunn RW (1994) The alpha-2 antagonists idazoxan and rauwolscine but not yohimbine or piperoxan are anxiolytic in the Vogel lick-shock conflict paradigm following intravenous administration. Life Sci 54:PL179-PL184
36. Laprade N, Radja F, Reader TA, Soghomonian JJ (1996) Dopamine receptor agonists regulate levels of the serotonin 5-HT2A receptor and its mRNA in a subpopulation of rat striatal neurons. J Neurosci 16:3727-3736
37. Lopez-Gimenez JF, Vilaro MT, Palacios JM, Mengod G (2001) Mapping of 5-HT2A receptors and their mRNA in monkey brain: [3H]MDL 100,907 autoradiography and in situ hybridization studies. J Comp Neurol 429:571-589
38. Marek GJ, Aghajanian GK (1999) 5-HT2A receptor or alpha1-adrenoceptor activation induces excitatory post-synaptic currents in layer V pyramidal cells of the medial prefrontal cortex. Eur J Pharmacol 367:197-206
39. Massé F, Hascoet M, Bourin M (2005) The implication of alpha2-adrenergic receptors in the mechanism of action of antidepressants in the four-plate test. Behav Brain Res 167:17-28
40. Matsumoto K, Mizowaki M, Thongpraditchote S, Murakami Y, Watanabe H (1997) alpha2-Adrenoceptor antagonists reverse the 5-HT2 receptor antagonist suppression of head-twitch behavior in mice. Pharmacol Biochem Behav 56:417-422
41. Millan MJ, Lejeune F, Gobert A, Brocco M, Auclair A, Bosc C, Rivet JM, Lacoste JM, Cordi A, Dekeyne A (2000) S18616, a highly potent spiroimidazoline agonist at alpha(2)-adrenoceptors. II. Influence on monoaminergic transmission, motor function, and anxiety in comparison with dexmedetomidine and clonidine. J Pharmacol Exp Ther 295:1206-1222
42. Miner LA, Backstrom JR, Sanders-Bush E, Sesack SR (2003) Ultrastructural localization of serotonin2A receptors in the middle layers of the rat prelimbic prefrontal cortex. Neuroscience 116:107-117
43. Morrow BA, George TP, Roth RH (2004) Noradrenergic alpha-2 agonists have anxiolytic-like actions on stress-related behavior and mesoprefrontal dopamine biochemistry. Brain Res 1027: 173-178
44. Nie Dhonnchadha BA, Bourin M, Hascoet M (2003a) Anxiolytic-like effects of 5-HT2 ligands on three mouse models of anxiety. Behav Brain Res 140:203-214
45. Nie Dhonnchadha BA, Hascoet M, Jolliet P, Bourin M (2003b) Evidence for a 5-HT2A receptor mode of action in the anxiolytic-like properties of DOI in mice. Behav Brain Res 147:175-184
46. Nie Dhonnchadha BA, Ripoll N, Clenet F, Hascoet M, Bourin M (2005) Implication of 5-HT(2) receptor subtypes in the mechanism of action of antidepressants in the four plates test. Psychopharmacology (Berl) 179:418-429
47. Numazawa R, Yoshioka M, Matsumoto M, Togashi H, Kemmotsu O, Saito H (1995) Pharmacological characterization of alpha 2-adrenoceptor regulated serotonin release in the rat hippocampus. Neurosci Lett 192:161-164
48. Onaivi ES, Bishop-Robinson C, Darmani NA, Sanders-Bush E (1995) Behavioral effects of (+/-)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane, (DOI) in the elevated plus-maze test. Life Sci 57:2455-2466
49. Pazos A, Cortes R, Palacios JM (1985) Quantitative autoradiographic mapping of serotonin receptors in the rat brain. II. Serotonin-2 receptors. Brain Res 346:231-249
50. Prieto M, Giralt MT (2001) Effects of N-(2-chloroethyl)-N-ethyl-2- bromobenzylamine (DSP4) on alpha2-adrenoceptors which regulate the synthesis and release of noradrenaline in the rat brain. Pharmacol Toxicol 88:152-158
51. Rasmussen K, Aghajanian GK (1986) Effect of hallucinogens on spontaneous and sensory-evoked locus coeruleus unit activity in the rat: reversal by selective 5-HT2 antagonists. Brain Res 385: 395-400
52. Rodgers RJ, Johnson NJT, Norton SJ, Cole JC (1995) Effect of ritanserin and 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) in the murine elevated plus-maze test of anxiety: an ethopharmacological study. J Psychopharmacol 9:38-42
53. Scheinin M, Lomasney JW, Hayden-Hixson DM, Schambra UB, Caron MG, Lefkowitz RJ, Fremeau RT Jr (1994) Distribution of alpha 2-adrenergic receptor subtype gene expression in rat brain. Brain Res Mol Brain Res 21:133-149
54. Schreiber R, Melon C, De Vry J (1998) The role of 5-HT receptor subtypes in the anxiolytic effects of selective serotonin reuptake inhibitors in the rat ultrasonic vocalization test. Psychopharmacology (Berl) 135:383-391
55. Scorza MC, Reyes-Parada M, Silveira R, Viola H, Medina JH, Viana MB, Zangrossi H, Jr, Graeff FG (1996) Behavioral effects of the putative anxiolytic (+/-)-1-(2,5-dimethoxy-4-ethylthiophenyl)-2-aminopropane (ALEPH-2) in rats and mice. Pharmacol Biochem Behav 54:355-361
56. Silverstone PH (2004) Qualitative review of SNRIs in anxiety. J Clin Psychiatry 65 (suppl) 17:19-28
57. Soderpalm B, Engel JA (1990) Alpha 1- and beta-adrenoceptor stimulation potentiate the anticonflict effect of a benzodiazepine. J Neural Transm Gen Sect 79:155-167
58. Sokal DM, Giarola AS, Large CH (2005) Effects of GABA(B), 5-HT(1A), and 5-HT(2) receptor stimulation on activation and inhibition of the rat lateral amygdala following medial geniculate nucleus stimulation in vivo. Brain Res 1031:141-150
59. Stine SM, Southwick SM, Petrakis IL, Kosten TR, Charney DS, Krystal JH (2002) Yohimbine-induced withdrawal and anxiety symptoms in opioid-dependent patients. Biol Psychiatry 51:642-651
60. Uhlen S, Muceniece R, Rangel N, Tiger G, Wikberg JE (1995) Comparison of the binding activities of some drugs on alpha 2A, alpha 2B and alpha 2C-adrenoceptors and non-adrenergic imidazoline sites in the guinea pig. Pharmacol Toxicol 76:353-364
61. Wamsley JK, Alburges ME, Hunt MA, Bylund DB (1992) Differential localization of alpha 2-adrenergic receptor subtypes in brain. Pharmacol Biochem Behav 41:267-273
62. Xu T, Pandey SC (2000) Cellular localization of serotonin(2A) (5HT(2A)) receptors in the rat brain. Brain Res Bull 51:499-505
63. Yu PH, Davis BA, Fang J, Boulton AA (1994) Neuroprotective effects of some monoamine oxidase-B inhibitors against DSP-4-induced noradrenaline depletion in the mouse hippocampus. J Neurochem 63:1820-1828
64. Zarrindast MR, Homayoun H, Babaie A, Etminani A, Gharib B (2000) Involvement of adrenergic and cholinergic systems in nicotine-induced anxiogenesis in mice. Eur J Pharmacol 407:145-158